These data establish a role for ECM remodeling due to MMPs caused by COL4A1/A2 mutations and provide in vitro evidence that modulating specific MMPs may represent therapeutic targets for SVD. This evidence concerns the gene COL4A1 and snowflake vitreoretinal degeneration.